These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 16914571

  • 1. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
    Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, Zhang Y, Xin DQ, Na YQ, Chen WF.
    Clin Cancer Res; 2006 Aug 15; 12(16):4851-8. PubMed ID: 16914571
    [Abstract] [Full Text] [Related]

  • 2. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M.
    Oncol Rep; 2005 Mar 15; 13(3):531-7. PubMed ID: 15706429
    [Abstract] [Full Text] [Related]

  • 3. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec 15; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 4. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkorn I.
    Cancer; 1998 Jan 15; 82(2):349-54. PubMed ID: 9445193
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer].
    Zhang Z, Hao H, Zhang CJ, Yang XY, He Q, Lin J.
    Zhonghua Yi Xue Za Zhi; 2012 Feb 14; 92(6):384-7. PubMed ID: 22490897
    [Abstract] [Full Text] [Related]

  • 6. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [Abstract] [Full Text] [Related]

  • 7. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion.
    Wang F, Li X, Xie X, Zhao L, Chen W.
    FEBS Lett; 2008 Jun 11; 582(13):1919-27. PubMed ID: 18501714
    [Abstract] [Full Text] [Related]

  • 8. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J.
    Clin Cancer Res; 2007 Dec 15; 13(24):7296-304. PubMed ID: 18094410
    [Abstract] [Full Text] [Related]

  • 9. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D, Abrol N, Khan R, Sharma M, Seth A, Sharma A.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1641-6. PubMed ID: 22626996
    [Abstract] [Full Text] [Related]

  • 10. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
    Lokeshwar VB, Obek C, Soloway MS, Block NL.
    Cancer Res; 1997 Feb 15; 57(4):773-7. PubMed ID: 9044859
    [Abstract] [Full Text] [Related]

  • 11. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG, Erbersdobler A, Schwaibold H, Conrad S, Huland E, Huland H.
    J Urol; 2000 Mar 15; 163(3):1039-42. PubMed ID: 10688045
    [Abstract] [Full Text] [Related]

  • 12. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
    Holyoake A, O'Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, Matsui Y, Ito M, Nishiyama H, Kerr N, da Silva Tatley F, Cambridge L, Toro T, Ogawa O, Guilford P.
    Clin Cancer Res; 2008 Feb 01; 14(3):742-9. PubMed ID: 18245534
    [Abstract] [Full Text] [Related]

  • 13. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
    Jamshidian H, Kor K, Djalali M.
    Urol J; 2008 Feb 01; 5(4):243-7. PubMed ID: 19101898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S, Swellam M, Shehata H, El-Khouly IM, El-Zayat T, El-Ahmady O.
    J Urol; 2010 Feb 01; 183(2):493-8. PubMed ID: 20006858
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T.
    APMIS; 2009 Jan 01; 117(1):45-52. PubMed ID: 19161536
    [Abstract] [Full Text] [Related]

  • 17. Recent advances in bladder cancer diagnostics.
    Sanchez-Carbayo M.
    Clin Biochem; 2004 Jul 01; 37(7):562-71. PubMed ID: 15234237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
    Lü Y, Tang D, Yu L, Ding Y, Liu L, Guo Y.
    Zhonghua Wai Ke Za Zhi; 2000 Apr 01; 38(4):294-6. PubMed ID: 12828175
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.